![](/img/cover-not-exists.png)
Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial
Hagiwara, Akiyoshi, Tanaka, Noriko, Uemura, Tatsuki, Matsuda, Wataru, Kimura, AkioVolume:
6
Language:
english
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2016-012850
Date:
December, 2016
File:
PDF, 1.07 MB
english, 2016